Home
Impact
About Us
Contact Us
NIHR Imperial BRC Team
Equality, Diversity and Inclusion (EDI) Strategy
NIHR Infrastructures
Acknowledgement
Research Guidance & Useful Links
NIHR Imperial BRC Branding Guidance
Research
Biomedical Engineering
Brain Sciences
Cardiovascular
Digestive Diseases
Digital Health
Immunology
Infection & Antimicrobial Resistance
Metabolic & Endocrinology
Molecular Phenotyping
Multiple Long-term Conditions (MLTC)
Pregnancy & Prematurity
Respiratory
Social, Genetic & Environmental Determinants of Health (SGE)
Surgery & Cancer
Facilities/Services
Clinical Imaging Facility
Clinical Phenotyping Centre
Flow Cytometry
Genomics Facility
Imperial College Healthcare Tissue Bank
iCARE
Imperial Clinical Trials Unit
Imperial Health Knowledge Bank (IHKB)
Organoid Facility
Patient Experience Research Centre (PERC)
The Leonard and Dora Colebrook Laboratory
Patient/Public
Research We Are Supporting
How You Can Get Involved
Information for Researchers
Public Involvement, Engagement and Participation in Research Summary Strategy
Industry/Partners
Primary Care Research Unit/Centre
Collaborations
Contract
Commercialisation
Training
Non-Medical Opportunities
Chain Florey Clinician Scientist Programme
Clinical Academic Training Office
Other Training Schemes
News & Events
Upcoming Events
Newsletter
Diagnostic Stories
Diagnostic
Using Next-Generation Sequencing to inform and control an outbreak
Published on
27
th
June 2016
Device
Diagnostic
Partnership
Therapeutic
Imperial Confidence in Concept Scheme Awards 2016
Published on
26
th
June 2016
Diagnostic
Therapeutic
The Anglo-Scandinavian Cardiac Outcomes Trial and related studies
Published on
26
th
June 2016
Diagnostic
Ripple Mapping
Published on
26
th
June 2016
Diagnostic
The application of measures of minimal residual disease to chronic myeloid leukaemia
Published on
26
th
June 2016
« Previous page
Information for Patients and the Public
Research We Are Supporting
How You Can Get Involved
Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
Impact
Innovation
Therapeutic
Pfizer Aims to Bring Imperial Obesity Drug Candidates to Clinic in $4.9bn Deal
Guideline
PPIE
Imperial BRC Theme Lead Contributes to Patient-led Global Heart Hub Manifesto
Guideline
Progress Against Chronic Disease Deaths is Declining